Microgenics 100075 - Toxicology Reagent DRI® Ecstasy (MDMA) CLIA Non-Waived For Clinical Chemistry Analyzers - 1/Kit
- The DRI® Ecstasy Enzyme Immunoassay is a homogeneous enzyme immunoassay intended for the qualitative or semiquantitative determination of ecstasy drugs in human urine
- The assay provides a simple and rapid analytical screening procedure for detecting ecstasy drugs at a cutoff level of 500 ng/mL
- Qualitative or semi-quantitative options for results
This product can be found in our Diagnostics -> Clinical Laboratory -> Laboratory Equipment -> Clinical Analyzers and Accessories -> Reagents section.
- SKU
- 100-1254873KT
Description / Microgenics 100075 - Toxicology Reagent DRI® Ecstasy (MDMA) CLIA Non-Waived For Clinical Chemistry Analyzers - 1/Kit
The Microgenics DRI Ecstasy (MDMA) toxicology reagent is a ready-to-use liquid supplied in a bottle. It is made for clinical chemistry analyzers and is used with urine samples. It is classed as CLIA non-waived.
- Toxicology reagent for Ecstasy (MDMA) from the DRI series
- CLIA non-waived
- For use with clinical chemistry analyzers
- Ready-to-use liquid form
- Urine sample type
- Bottle container, 100 mL volume
- Manufacturer number 100075
Check that your clinical chemistry analyzer is compatible with this reagent before ordering.
More Information
| Unit Of Measure | Kit |
|---|---|
| Buy American Act (BAA) Compliant | No |
| Trade Agreement Act (TAA) Compliant | No |
| UNSPSC Code | 41116007 |
| Manufacturer Name | Microgenics |
| Manufacturer Number | 100075 |
| Application | Toxicology Reagent |
| Brand Or Series | DRI® |
| Qty Per Unit of Measure | 1 |
| Container Type | Bottle |
| Form | Ready-to-Use Liquid |
| For Use With | For Clinical Chemistry Analyzers |
| Volume | 100 mL |
| Sample Type | Urine Sample |